Preventative treatment of tuberous sclerosis complex with sirolimus: Phase I safety and efficacy results is a research paper published in Annals of the Child Neurology Society (2024). On theSindex it has a DataRank of 0. It has been cited 17 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Center for Advancing Translational Sciences
Grant: UL1TR001425
U.S. Food and Drug Administration
Grant: R01‐FD007275
FDA HHS
Grant: R01 FD007275
National Institutes of Health
Grant: 5R01FD007275-02
Sirolimus TSC Epilepsy Prevention Study (STEPS) IND#145820 11/8/2019
National Institutes of Health
Grant: 5U01NS092595-05
Preventing Epilepsy using Vigabatrin in Infants with Tuberous Sclerosis Complex
National Institutes of Health
Grant: 5UL1TR001425-03
Cincinnati Center for Clinical and Translational Sciences and Training
FWCI
4.16
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals